AIM
TEVA icon

AXA Investment Managers’s Teva Pharmaceuticals TEVA Stock Holding History

AXA Investment Managers’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$75.2K Buy
+3,722
New +$65.4K ﹤0.01% 1139

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

AXA Investment Managers's TEVA Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Teva Pharmaceuticals (TEVA) in Q3 2025: 3,722 shares worth $75.2K. The stake represents ﹤0.01% of the portfolio and ranks #1139 among its holdings.

550 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • AXA Investment Managers held 3,722 shares of Teva Pharmaceuticals worth $75.2K as of Q3 2025.
  • Teva Pharmaceuticals was a new AXA Investment Managers position in Q3 2025.
  • Teva Pharmaceuticals made up ﹤0.01% of AXA Investment Managers's portfolio in Q3 2025, its #1139 holding.
  • 550 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.